William Aliski, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,000 shares at $41.83 ($253K) on 2014-12-04, disclosed to the SEC on 2014-12-08.
Open-market sale of $253k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.83 | 2,891 | $121K | 47.8% |
| 2 | $42.46 | 3,109 | $132K | 52.2% |
| Total | $42.16 avg | 6,000 | $253K | 100% |
| Filing → |
| RARE | SELL | 2020-06-03 | $1.5M | — | Filing → |
| RARE | SELL | 2020-05-20 | $560K | — | Filing → |
| AGTC | BUY | 2018-12-18 | $19K | — | Filing → |